Transforming data into tangible innovations for patients
To make this approach a reality, the AI & Cancer Consortium is multiplying projects, testing national data against industrial questions, and working on their admissibility with regulatory authorities, particularly through an ongoing dialogue with the French National Authority for Health (HAS).
The creation of this partnership between public and private sectors demonstrates a shared desire to accelerate cancer research and make France an attractive, world-class reference ecosystem.
Making France a world-class reference ecosystem
From idea to results, we support every project
The AI & Cancer Consortium supports each project leader from the ideation phase through to the results.
The projects receiving support are selected by the Association’s Board of Directors based on three main categories of criteria: their innovative nature, their scalability, and their potential for the national ecosystem.
- Innovating Through Projects
- Building on Successes
- Promoting the Ecosystem
Ministry of Economy and Finance, Paris
Consortium's Day
IA & Cancers 2026
The AI & Cancer Consortium Day is back for its third edition to bring the ecosystem together and tangibly accelerate the development of AI in oncology.